Evolving CML Research: Assessing the Need for Ongoing Treatment in Clinical Trials


Is there such thing as treatment-free remission for a CML patient?  Dr. Jessica Altman of Robert H. Lurie Comprehensive Cancer Center of Northwestern University shares data about novel treatments coming from current clinical trials. The most exciting news is the major advance in treatment-free remission for patients in molecular remission. Dr. Altman expands on this notion and discusses the new therapy, ABL001, currently being studied.  

Sign in or Register to view comments.